• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在DNA疫苗设计中对fimH的哺乳动物密码子使用情况的评估。

Evaluation of mammalian codon usage of fimH in DNA vaccine design.

作者信息

Bagherpour Ghasem, Fooladi Abbas Ali Imani, Mehrabadi Jalil Fallah, Nourani Mohammad Reza, Einollahi Behzad

机构信息

Baqiyatallah University of Medical, Sciences Tehran Iran.

出版信息

Acta Microbiol Immunol Hung. 2011 Dec;58(4):259-71. doi: 10.1556/AMicr.58.2011.4.2.

DOI:10.1556/AMicr.58.2011.4.2
PMID:22207284
Abstract

Uropathogenic Escherichia coli (UPEC) bacteria are the principal cause of urinary tract infections (UTI). Because these bacteria propagate intracellularly, the cellular immune response is an important factor in UTIs. Therefore, we designed a genetic construct to induce a cellular immune response. In order to develop a genetic construct that induces strong cellular immunity against this pathogen, we used the fimH synthetic gene according to mammalian codon usage, and the gene expression was compared with wild type codon usage. Initially, we designed two constructs, pVAX/fimH mam and pVAX/fimH wt, which contain mammalian and wild type codon usage, respectively. The Cos-7 cell line was transfected separately with a complex of pVAX/fimH mam-ExGene 500 poly cationic polymer and pVAX/fimH wt-ExGene 500 poly cationic polymer. Expression of the fimH gene in both constructs in COS7 cells was confirmed by RT-PCR, SDS-PAGE, and Western blotting. Both of the pVAX/fimH cassettes expressed inserted fimH genes (mam and wt) in Cos-7 cells. Our results suggest that codon optimization successfully expressed the fimH gene because the fimH gene with mammalian codon usage is compatible with the eukaryotic expression system. Therefore, mammalian codon usage could be appropriate in a pVAX/fimH construct as a DNA vaccine.

摘要

尿路致病性大肠杆菌(UPEC)是尿路感染(UTI)的主要病因。由于这些细菌在细胞内繁殖,细胞免疫反应是尿路感染的一个重要因素。因此,我们设计了一种基因构建体来诱导细胞免疫反应。为了开发一种能诱导针对这种病原体产生强大细胞免疫的基因构建体,我们根据哺乳动物密码子使用情况使用了fimH合成基因,并将该基因表达与野生型密码子使用情况进行了比较。最初,我们设计了两种构建体,即分别包含哺乳动物密码子使用情况和野生型密码子使用情况的pVAX/fimH mam和pVAX/fimH wt。用pVAX/fimH mam-ExGene 500聚阳离子聚合物复合物和pVAX/fimH wt-ExGene 500聚阳离子聚合物复合物分别转染Cos-7细胞系。通过RT-PCR、SDS-PAGE和Western印迹法证实了两种构建体中fimH基因在COS7细胞中的表达。两个pVAX/fimH盒式结构均在Cos-7细胞中表达了插入的fimH基因(mam和wt)。我们的结果表明密码子优化成功表达了fimH基因,因为具有哺乳动物密码子使用情况的fimH基因与真核表达系统兼容。因此,在作为DNA疫苗的pVAX/fimH构建体中,哺乳动物密码子使用情况可能是合适的。

相似文献

1
Evaluation of mammalian codon usage of fimH in DNA vaccine design.在DNA疫苗设计中对fimH的哺乳动物密码子使用情况的评估。
Acta Microbiol Immunol Hung. 2011 Dec;58(4):259-71. doi: 10.1556/AMicr.58.2011.4.2.
2
Cellular immunity survey against urinary tract infection using pVAX/fimH cassette with mammalian and wild type codon usage as a DNA vaccine.使用具有哺乳动物和野生型密码子使用方式的pVAX/fimH盒作为DNA疫苗针对尿路感染的细胞免疫调查。
Clin Exp Vaccine Res. 2014 Jul;3(2):185-93. doi: 10.7774/cevr.2014.3.2.185. Epub 2014 Jun 20.
3
Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.重组 FimH 与鞭毛蛋白融合疫苗增强小鼠尿路感染的细胞和体液免疫。
Vaccine. 2013 Feb 6;31(8):1210-6. doi: 10.1016/j.vaccine.2012.12.059. Epub 2013 Jan 7.
4
Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic .由尿路致病性菌毛粘附素产生的二聚体和三聚体融合蛋白
Front Cell Infect Microbiol. 2016 Oct 31;6:135. doi: 10.3389/fcimb.2016.00135. eCollection 2016.
5
Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis.鼻腔内免疫融合蛋白 MrpH·FimH 和 MPL 佐剂可预防由尿路致病性大肠杆菌和奇异变形杆菌引起的尿路感染。
Mol Immunol. 2015 Apr;64(2):285-94. doi: 10.1016/j.molimm.2014.12.008. Epub 2015 Jan 4.
6
In silico and in vivo studies of truncated forms of flagellin (FliC) of enteroaggregative Escherichia coli fused to FimH from uropathogenic Escherichia coli as a vaccine candidate against urinary tract infections.肠聚集性大肠杆菌鞭毛蛋白(FliC)截短形式与尿路致病性大肠杆菌 FimH 融合的体内外研究作为尿路感染疫苗候选物。
J Biotechnol. 2014 Apr 10;175:31-7. doi: 10.1016/j.jbiotec.2014.01.037. Epub 2014 Feb 12.
7
Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis.用融合蛋白MrpH.FimH进行经尿道灌注可诱导针对尿路致病性大肠杆菌和奇异变形杆菌的保护性固有免疫反应。
APMIS. 2016 Jun;124(6):444-52. doi: 10.1111/apm.12523. Epub 2016 Feb 26.
8
Construction and development of FimH lectin domain for rising immune response after injection by uropathogenic E. coli.通过注射尿路致病性大肠杆菌来提高免疫应答的 FimH 凝集素结构域的构建和开发。
Hum Antibodies. 2020;28(2):169-178. doi: 10.3233/HAB-200404.
9
[Construction and characterization of type I fimbriae fimH deletion mutant from avian pathogenic Escherichia coli].[禽致病性大肠杆菌I型菌毛fimH缺失突变株的构建与鉴定]
Wei Sheng Wu Xue Bao. 2008 Feb;48(2):252-6.
10
Assessment of immune responses of the flagellin (FliC) fused to FimH adhesin of Uropathogenic Escherichia coli.评估与尿道致病性大肠埃希菌 FimH 黏附素融合的鞭毛蛋白(FliC)的免疫反应。
Mol Immunol. 2013 May;54(1):32-9. doi: 10.1016/j.molimm.2012.11.002. Epub 2012 Dec 3.

引用本文的文献

1
Urinary Tract Infections Caused by Uropathogenic : Mechanisms of Infection and Treatment Options.尿路感染的病原体:感染机制和治疗选择。
Int J Mol Sci. 2023 Jun 23;24(13):10537. doi: 10.3390/ijms241310537.
2
Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.用于治疗和预防尿路感染的药物与疫苗研发
Microbiol Spectr. 2016 Feb;4(1). doi: 10.1128/microbiolspec.UTI-0013-2012.
3
Cellular immunity survey against urinary tract infection using pVAX/fimH cassette with mammalian and wild type codon usage as a DNA vaccine.
使用具有哺乳动物和野生型密码子使用方式的pVAX/fimH盒作为DNA疫苗针对尿路感染的细胞免疫调查。
Clin Exp Vaccine Res. 2014 Jul;3(2):185-93. doi: 10.7774/cevr.2014.3.2.185. Epub 2014 Jun 20.
4
Codon preference optimization increases prokaryotic cystatin C expression.密码子偏好性优化可提高原核细胞中胱抑素C的表达。
J Biomed Biotechnol. 2012;2012:732017. doi: 10.1155/2012/732017. Epub 2012 Oct 3.